Suppr超能文献

在病例对照研究中,比值比估计的是什么?

What does the odds ratio estimate in a case-control study?

作者信息

Pearce N

机构信息

Department of Medicine, Wellington School of Medicine, New Zealand.

出版信息

Int J Epidemiol. 1993 Dec;22(6):1189-92. doi: 10.1093/ije/22.6.1189.

Abstract

The use of the term 'odds ratio' in reporting the findings of case-control studies is technically correct, but is often misleading. The meaning of the odds ratio estimates obtained in a case-control study differs according to whether controls are selected from person-time at risk (the study base), persons at risk (the base-population at risk at the beginning of follow-up), or survivors (the population at risk at the end of follow-up). These three methods of control selection correspond to estimating the rate ratio, risk ratio, or the odds ratio respectively, by means of calculating the odds ratio in the subjects actually studied. None of these estimation procedures depends on any rare disease assumption. Where the rare disease assumption is relevant is whether the effect which is estimated (e.g. the odds ratio) is approximately equal to some other effect measure of interest (e.g. the risk ratio or rate ratio) in the underlying study base. To avoid confusion on this issue, authors should be encouraged to not only specify the manner in which controls have been selected (e.g. by density sampling) but also the corresponding effect measure which is being estimated (e.g. the rate ratio) by the 'odds ratio' which is obtained in a case-control analysis.

摘要

在报告病例对照研究结果时使用“比值比”一词在技术上是正确的,但常常具有误导性。在病例对照研究中获得的比值比估计值的含义,会因对照是从处于风险中的人时(研究基数)、处于风险中的人(随访开始时的风险基数人群)还是幸存者(随访结束时的风险人群)中选取而有所不同。这三种选择对照的方法分别对应于通过计算实际研究对象中的比值比来估计发病率比、风险比或比值比。这些估计程序均不依赖于任何罕见病假设。罕见病假设相关的地方在于,在基础研究基数中,所估计的效应(如比值比)是否近似等于其他一些感兴趣的效应量度(如风险比或发病率比)。为避免在这个问题上产生混淆,应鼓励作者不仅要指明选择对照的方式(如通过密度抽样),还要指明通过病例对照分析中获得的“比值比”所估计的相应效应量度(如发病率比)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验